KMTS insider transaction filings
KESTRA MEDICAL TECHNOLOGIES, LTD. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-09-10. Screen KMTS transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 24 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 32 legs across 16 filings by 9 insiders — 254,588 shares, $6,139,528 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 48,625 shares @ $24.47 ($1,189,815) by Webster Brian Daniel, filed 2026-08-06.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Webster Brian Daniel — See Remarks, Director | 4 | — | 10 legs · 111,722 sh · $2,713,592 | 1 |
| Mahboob Vaseem — Chief Financial Officer | 4 | — | 7 legs · 51,470 sh · $1,271,235 | 1 |
| Ford Alfred J Jr — Chief Commercial Officer | 3 | — | 4 legs · 33,907 sh · $793,664 | 1 |
| Umberger Traci S — See Remarks, Director | 4 | — | 4 legs · 25,809 sh · $598,864 | 2 |
| Moran Timothy P. — Chief Business Officer | 3 | — | 3 legs · 15,256 sh · $348,311 | 2 |
| Hanley Conor — Director | 1 | — | 1 leg · 5,694 sh · $143,779 | 1 |
| Ladone Mary Kay — Director | 1 | — | 1 leg · 3,908 sh · $98,464 | 1 |
| Schwartz Jeffrey Lawrence — Director, 10% owner | 1 | — | 1 leg · 3,890 sh · $97,942 | 1 |
| Reilly Kevin C — Director | 1 | — | 1 leg · 2,932 sh · $73,677 | 1 |
| COHEN RAYMOND W — Director | 1 | — | — | 1 |
+1 more insider in the window, not shown — every filing appears in the table below.
Recent Form 4 filings — KESTRA MEDICAL TECHNOLOGIES, LTD.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-10 | 4 | Schwartz Jeffrey Lawrence — Director, 10% owner | Sale (S): 3,890 @ $25.18 · Grant/award (A): 7,217 | EDGAR |
| 2026-09-10 | 4 | COHEN RAYMOND W — Director | Grant/award (A): 7,217 | EDGAR |
| 2026-09-10 | 4 | Kwo Elizabeth — Director | Grant/award (A): 7,217 | EDGAR |
| 2026-09-10 | 4 | Hanley Conor — Director | Sale (S): 5,694 @ $25.25 · Grant/award (A): 7,217 | EDGAR |
| 2026-09-10 | 4 | Ladone Mary Kay — Director | Sale (S): 3,908 @ $25.20 · Grant/award (A): 7,217 | EDGAR |
| 2026-09-10 | 4 | Reilly Kevin C — Director | Sale (S): 2,932 @ $25.13 · Grant/award (A): 7,217 | EDGAR |
| 2026-08-18 | 4 | Webster Brian Daniel — See Remarks, Director | Sale (S): 15,000 @ $27.48 | EDGAR |
| 2026-08-11 | 4 | Mahboob Vaseem — Chief Financial Officer | Sale (S): 25,787 @ $25.87 · Sale (S): 500 @ $26.33 | EDGAR |
| 2026-08-06 | 4 | Ford Alfred J Jr — Chief Commercial Officer | Sale (S): 6,275 @ $24.09 | EDGAR |
| 2026-08-06 | 4 | Mahboob Vaseem — Chief Financial Officer | Sale (S): 3,080 @ $24.06 · Sale (S): 3,915 @ $25.17 | EDGAR |
| 2026-08-06 | 4 | Webster Brian Daniel — See Remarks, Director | Sale (S): 48,625 @ $24.47 · Sale (S): 2,833 @ $25.16 · Sale (S): 442 @ $25.98 | EDGAR |
| 2026-08-06 | 4 | Umberger Traci S — See Remarks, Director | Sale (S): 3,580 @ $24.04 | EDGAR |
| 2026-08-03 | 4 | Moran Timothy P. — Chief Business Officer | Sale (S): 4,117 @ $22.77 · Sale (S): 8,759 @ $22.61 · Sale (S): 2,380 @ $23.76 | EDGAR |
| 2026-08-03 | 4 | Ford Alfred J Jr — Chief Commercial Officer | Sale (S): 5,936 @ $22.76 · Sale (S): 8,681 @ $22.61 · Sale (S): 13,015 @ $23.90 | EDGAR |
| 2026-08-03 | 4 | Umberger Traci S — See Remarks, Director | Sale (S): 5,887 @ $22.74 · Sale (S): 8,752 @ $22.60 · Sale (S): 7,590 @ $23.86 | EDGAR |
| 2026-08-03 | 4 | Mahboob Vaseem — Chief Financial Officer | Sale (S): 3,980 @ $22.75 · Sale (S): 8,817 @ $22.61 · Sale (S): 5,391 @ $23.80 | EDGAR |
| 2026-08-03 | 4 | Webster Brian Daniel — See Remarks, Director | Sale (S): 7,857 @ $22.72 · Sale (S): 8,948 @ $22.60 · Sale (S): 13,017 @ $23.92 | EDGAR |
| 2026-07-17 | 4 | Umberger Traci S — See Remarks, Director | Grant/award (A): 58,832 @ $0 | EDGAR |
| 2026-07-17 | 4 | Webster Brian Daniel — See Remarks, Director | Grant/award (A): 176,470 @ $0 · Sale (S): 11,216 @ $22.01 · Sale (S): 784 @ $22.63 · Sale (S): 3,000 @ $24.00 | EDGAR |
| 2026-07-17 | 4 | Moran Timothy P. — Chief Business Officer | Grant/award (A): 39,113 @ $0 | EDGAR |
| 2026-07-17 | 4 | Mahboob Vaseem — Chief Financial Officer | Grant/award (A): 44,118 @ $0 | EDGAR |
| 2026-07-17 | 4 | Ford Alfred J Jr — Chief Commercial Officer | Grant/award (A): 58,832 @ $0 | EDGAR |
| 2026-07-02 | 4 | Umberger Traci S — See Remarks, Director | Grant/award (A): 942 @ $21.55 | EDGAR |
| 2026-07-02 | 4 | Moran Timothy P. — Chief Business Officer | Grant/award (A): 227 @ $21.55 | EDGAR |
| 2026-06-17 | 4 | Webster Brian Daniel — See Remarks, Director | Sale (S): 15,000 @ $20.81 | EDGAR |
| 2026-06-04 | 4 | Umberger Traci S — See Remarks, Director | Grant/award (A): 25,227 @ $0 | EDGAR |
| 2026-06-04 | 4 | Webster Brian Daniel — See Remarks, Director | Grant/award (A): 75,681 @ $0 | EDGAR |
| 2026-06-04 | 4 | Moran Timothy P. — Chief Business Officer | Grant/award (A): 22,704 @ $0 | EDGAR |
| 2026-06-04 | 4 | Mahboob Vaseem — Chief Financial Officer | Grant/award (A): 25,227 @ $0 | EDGAR |
| 2026-06-04 | 4 | Ford Alfred J Jr — Chief Commercial Officer | Grant/award (A): 25,227 @ $0 | EDGAR |
| 2026-05-18 | 4 | Webster Brian Daniel — See Remarks, Director | Sale (S): 8,155 @ $20.53 · Sale (S): 6,845 @ $21.46 | EDGAR |
| 2026-04-16 | 4 | Webster Brian Daniel — See Remarks, Director | Sale (S): 15,000 @ $20.04 | EDGAR |
| 2026-03-30 | 4 | COHEN RAYMOND W — Director | Purchase (P): 10,000 @ $19.98 | EDGAR |
| 2026-03-19 | 4 | Webster Brian Daniel — See Remarks, Director | Sale (S): 15,000 @ $20.27 | EDGAR |
| 2026-03-12 | 4 | Reilly Kevin C — Director | Grant/award (A): 8,300 | EDGAR |
| 2026-02-19 | 4 | Webster Brian Daniel — See Remarks, Director | Sale (S): 11,635 @ $25.39 · Sale (S): 3,272 @ $26.29 · Sale (S): 93 @ $27.18 | EDGAR |
| 2026-01-20 | 4 | Webster Brian Daniel — See Remarks, Director | Sale (S): 15,000 @ $22.80 | EDGAR |
| 2025-12-31 | 4 | Umberger Traci S — See Remarks, Director | Sale (S): 10,500 @ $26.69 | EDGAR |
| 2025-12-31 | 4 | Webster Brian Daniel — See Remarks, Director | Sale (S): 15,000 @ $26.59 | EDGAR |
| 2025-12-04 | 4 | Moran Timothy P. — Chief Business Officer | Grant/award (A): 19,557 | EDGAR |
| 2025-09-15 | 4/A | Umberger Traci S — See Remarks, Director | Purchase (P): 13,500 @ $17 | EDGAR |
| 2025-09-15 | 4/A | Ford Alfred J Jr — Chief Commercial Officer | Purchase (P): 20,000 @ $17 | EDGAR |
| 2025-09-08 | 4 | Hanley Conor — Director | Grant/award (A): 13,120 | EDGAR |
| 2025-09-08 | 4 | Kwo Elizabeth — Director | Grant/award (A): 10,909 | EDGAR |
| 2025-09-08 | 4 | Ladone Mary Kay — Director | Grant/award (A): 10,909 | EDGAR |
| 2025-09-08 | 4 | Schwartz Jeffrey Lawrence — Director, 10% owner | Grant/award (A): 10,909 | EDGAR |
| 2025-09-08 | 4 | COHEN RAYMOND W — Director | Purchase (P): 17,000 @ $17 · Grant/award (A): 10,909 | EDGAR |
| 2025-07-24 | 4 | COHEN RAYMOND W — Director | Grant/award (A): 12,994 | EDGAR |
| 2025-07-21 | 4 | Mahboob Vaseem — Chief Financial Officer | Grant/award (A): 22,059 @ $0 | EDGAR |
| 2025-07-21 | 4 | Ford Alfred J Jr — Chief Commercial Officer | Grant/award (A): 29,412 @ $0 | EDGAR |
Recent 8-K events — KESTRA MEDICAL TECHNOLOGIES, LTD.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-14 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-10 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-07-14 | 8-K | 1.01 — Entry into a Material Definitive Agreement 1.02 — Termination of a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-17 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-04 | 8-K | 1.01 — Entry into a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-01 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-10 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-04 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=KMTS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →